218 related articles for article (PubMed ID: 34011803)
41. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
42. Novel genes in primary aldosteronism.
Fischer E; Beuschlein F
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
[TBL] [Abstract][Full Text] [Related]
43. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
[TBL] [Abstract][Full Text] [Related]
44. Role of KCNJ5 in familial and sporadic primary aldosteronism.
Mulatero P; Monticone S; Rainey WE; Veglio F; Williams TA
Nat Rev Endocrinol; 2013 Feb; 9(2):104-12. PubMed ID: 23229280
[TBL] [Abstract][Full Text] [Related]
45. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
[TBL] [Abstract][Full Text] [Related]
46. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.
Zhou J; Lam B; Neogi SG; Yeo GS; Azizan EA; Brown MJ
Hypertension; 2016 Dec; 68(6):1424-1431. PubMed ID: 27777363
[TBL] [Abstract][Full Text] [Related]
47. Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.
Gagnon N; Cáceres-Gorriti KY; Corbeil G; El Ghoyareb N; Ludwig N; Latour M; Lacroix A; Bourdeau I
J Clin Endocrinol Metab; 2018 Aug; 103(8):2926-2935. PubMed ID: 29726953
[TBL] [Abstract][Full Text] [Related]
48. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
[TBL] [Abstract][Full Text] [Related]
49. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Scholl UI; Goh G; Stölting G; de Oliveira RC; Choi M; Overton JD; Fonseca AL; Korah R; Starker LF; Kunstman JW; Prasad ML; Hartung EA; Mauras N; Benson MR; Brady T; Shapiro JR; Loring E; Nelson-Williams C; Libutti SK; Mane S; Hellman P; Westin G; Åkerström G; Björklund P; Carling T; Fahlke C; Hidalgo P; Lifton RP
Nat Genet; 2013 Sep; 45(9):1050-4. PubMed ID: 23913001
[TBL] [Abstract][Full Text] [Related]
50. Unravelling the Genetic Basis of Primary Aldosteronism.
Mourtzi N; Sertedaki A; Markou A; Piaditis GP; Charmandari E
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33800142
[TBL] [Abstract][Full Text] [Related]
51. Overview of the genetic determinants of primary aldosteronism.
Al-Salameh A; Cohen R; Desailloud R
Appl Clin Genet; 2014; 7():67-79. PubMed ID: 24817817
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
[TBL] [Abstract][Full Text] [Related]
53. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Amar L; Plouin PF; Steichen O
Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
[TBL] [Abstract][Full Text] [Related]
54. Overview of aldosterone-related genetic syndromes and recent advances.
Zennaro MC; Fernandes-Rosa FL; Boulkroun S
Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):147-154. PubMed ID: 29432258
[TBL] [Abstract][Full Text] [Related]
55. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
56. Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
Vouillarmet J; Fernandes-Rosa F; Graeppi-Dulac J; Lantelme P; Decaussin-Petrucci M; Thivolet C; Peix JL; Boulkroun S; Clauser E; Zennaro MC
J Clin Endocrinol Metab; 2016 Nov; 101(11):3874-3878. PubMed ID: 27648962
[TBL] [Abstract][Full Text] [Related]
57. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
[TBL] [Abstract][Full Text] [Related]
58. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
[TBL] [Abstract][Full Text] [Related]
59. Pathogenesis and treatment of primary aldosteronism.
Zennaro MC; Boulkroun S; Fernandes-Rosa FL
Nat Rev Endocrinol; 2020 Oct; 16(10):578-589. PubMed ID: 32724183
[TBL] [Abstract][Full Text] [Related]
60. Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas.
Williams TA; Peitzsch M; Dietz AS; Dekkers T; Bidlingmaier M; Riester A; Treitl M; Rhayem Y; Beuschlein F; Lenders JW; Deinum J; Eisenhofer G; Reincke M
Hypertension; 2016 Jan; 67(1):139-45. PubMed ID: 26573708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
